All articles
)
Infermedica 2020: Year in review
Infermedica navigated through 2020 and despite all obstacles, we kept supporting global healthcare to bring better health services. See what we achieved.
)
How COVID-19 symptom checkers remade the user paths
COVID-19 symptom checkers were a small and yet important step towards the digitization of healthcare. Let's see reshaped patient paths.
)
How symptom checkers are helping us deal with the pandemic
Although symptom checkers are not diagnosing nor curing coronavirus, they have turned out to be a great support in the fight against the pandemic.
)
Specialist Recommender is now available
Meet our new tool that adds recommendations of the physician and communication channel, to our pre-diagnosis processes.
)
Microsoft's bot to aid global healthcare
Microsoft has empowered multiple healthcare organizations with a fast and accurate pre-diagnosis tool. See how it uses Intermedia API.
)
Regression testing in validation of medical content
See how we use regression testing to investigate and improve the Infermedica database, which interlinks hundreds of symptoms and conditions.
)
Diagnostikare, end-to-end digital health services for enterprises
See how Infermedica API is used in Diagnostikare, a Mexican digital platform offering health services for patients and enterprises.
)
Areas to check before launching a healthcare app on Infermedica API
Everything you should know and double-check before launching the new healthcare application based on Infermedica API.
)
The multi-step clinical validation process at Infermedica
Validation is a vital part of creating medical content at Infermedica. See our testing methods and ways to improve the medical knowledge base.
)
Building a quality digital medical knowledge base
Our medical information base lies at the very heart of Infermedica solutions. We present 6 things that are the key to its quality and accuracy.
)
Sana Kliniken AG implements symptom checker
We formed a partnership with Sana Kliniken, one of the largest German healthcare providers.
)
Infermedica closes Series A funding with $10.25M
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
)